|
|
| | (Val438)-Tyrosinase (432-444) (human) Basic information |
| Product Name: | (Val438)-Tyrosinase (432-444) (human) | | Synonyms: | (Val438)-Tyrosinase (432-444) (human);(Val438)-Tyrosinase (432-444) (huMan)
(Val438)-LB24-AB (432-444) (huMan), (Val438)-Monophenol Monooxygenase (432-444) (huMan), (Val438)-SK29-AB (432-444) (huMan), (Val438)-TuMor Rejection Antigen AB (432-444) (huMan);(Val438)-LB24-AB (432-444) (huMan), (Val438)-Monophenol Monooxygenase (432-444) (huMan), (Val438)-SK29-AB (432-444) (huMan), (Val438)-TuMor Rejection Antigen AB (432-444) (huMan);H-Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp-OH;L-Aspartic acid, L-seryl-L-tyrosyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-seryl-L-valyl-L-prolyl-L-α-aspartyl-L-seryl-L-phenylalanyl-L-glutaminyl- (9CI);24:PN:WO0216560 SEQID:56 unclaimed sequence;(Val???)-Tyrosinase (432-444) (human) acetate salt;Tyrosinase (432 - 444) (human) | | CAS: | 320341-56-8 | | MF: | C65H93N15O26 | | MW: | 1500.52 | | EINECS: | | | Product Categories: | | | Mol File: | 320341-56-8.mol |  |
| | (Val438)-Tyrosinase (432-444) (human) Chemical Properties |
| Sequence | Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp |
| | (Val438)-Tyrosinase (432-444) (human) Usage And Synthesis |
| Uses | SYLQDSVPDSFQD, anchor-modified for high-affinity binding to DR4, is a DR4-restricted MHC class II peptide Tyrosinase[1]. | | References | [1] Schadendorf D, et al. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol. 2006 Apr;17(4):563-70. DOI:10.1093/annonc/mdj138 |
| | (Val438)-Tyrosinase (432-444) (human) Preparation Products And Raw materials |
|